Institutional shares held 4.83 Million
9.4K calls
6K puts
Total value of holdings $9.7M
$18K calls
$12K puts
Market Cap $102M
49,046,200 Shares Out.
Institutional ownership 9.84%
# of Institutions 31


Latest Institutional Activity in MNOV

Top Purchases

Q3 2024
Ubs Group Ag Shares Held: 305K ($632K)
Q3 2024
Geode Capital Management, LLC Shares Held: 506K ($1.05M)
Q3 2024
Susquehanna International Group, LLP Shares Held: 57K ($118K)
Q3 2024
Jane Street Group, LLC Shares Held: 14.1K ($29.3K)
Q3 2024
Goldman Sachs Group Inc Shares Held: 10.2K ($21.2K)

Top Sells

Q3 2024
Charles Schwab Investment Management Inc Shares Held: 71.5K ($148K)
Q3 2024
Bank Of America Corp Shares Held: 76.3K ($158K)
Q3 2024
Renaissance Technologies LLC Shares Held: 187K ($386K)
Q3 2024
Citadel Advisors LLC Shares Held: 1.43K ($2.96K)
Q3 2024
Dimensional Fund Advisors LP Shares Held: 61.3K ($127K)

About MNOV

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.


Insider Transactions at MNOV

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on MNOV

Follow MEDICINOVA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNOV shares.

Notify only if

Insider Trading

Get notified when an Medicinova Inc insider buys or sells MNOV shares.

Notify only if

News

Receive news related to MEDICINOVA INC

Track Activities on MNOV